VANCOUVER, Dec. 7 /CNW/ - ONDINE BIOPHARMA CORPORATION (TSX: OBP, AIM:
OBP) (the "Company") is pleased to announce that it has issued an additional
462,500 common shares of the Company at a price of $1.60 per share for gross
proceeds to the Company of $740,000 to an underwriting group led by Canaccord
Capital Corporation and including Desjardins Securities Inc. and Pacific
International Securities Inc. (collectively, the "Underwriters"). The 462,500
common shares were issued as a result of the Underwriters exercising a portion
of the over-allotment option granted in connection with a public offering that
closed on November 9, 2006, bringing the total gross proceeds to $10,740,000.
